Genovate Biotechnology Co., Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genovate Biotechnology Co., Limited with three other
companies in this sector in Taiwan:
UBI Pharma Inc
sales of 413.09 million Taiwanese Dollars [US$13.01 million]
of which 100%
was Single Segment),
TSH Biopharm Corp Limited
(513.65 million Taiwanese Dollars [US$16.18 million]
Twi Pharmaceuticals Inc
(437.37 million Taiwanese Dollars [US$13.78 million]
of which 96%
was Generic Drug).
During the year ended December of 2015, sales at
Genovate Biotechnology Co., Limited were 477.60 million Taiwanese Dollars (US$15.04 million).
a very small
increase of 0.5%
versus 2014, when the company's sales were 475.45 million Taiwanese Dollars.
This was the fourth straight year of sales growth at Genovate Biotechnology Co., Limited.